There are four main types of COVID-19 vaccines in use and in development: whole attenuated virus vaccines; subunit vaccines; viral vector vaccines ... development of the DNA vaccine that we ...

Although DNA or mRNA vaccines are easier to make ... be used to deliver more than one antigen, and, unlike viral vector-based vaccines, there is no risk of developing anti-vector immunity.

To make your genetic vaccine, you'll use vectors. Vectors are agents that are able to enter and instruct cells to create proteins based on the vector's DNA code. In this case, the vectors are ...

Immunizing the host with a piece of viral DNA rather than an antigenic protein fragment of the virus, helps to stimulate the generation of cell-mediated immunity (Fig. 2). DNA vaccines contain the ...

New HCV vaccine approaches, including peptide, recombinant protein, DNA and vector-based vaccines, have recently reached Phase I/II human clinical trials. Some of these technologies have generated ...

Renowned for its focus on developing cutting-edge DNA-based vaccines, Genetic Immunity has ... Its award-winning Vector Design Studio is a transformative innovation that allows researchers to ...

Neoantigens appear on the surface of the cell because of cancer-causing mutations within the cell's DNA. The LungVax vaccine will carry a strand of DNA which trains the immune system to recognize ...

Touchlight, an innovation-driven Contract Development and Manufacturing Organisation (CDMO), today announced that its facility in Hampton UK has received GMP certification. As a result, Touchlight ...